The Activated Clotting Time Testing Market is expected to growing with the CAGR of 4% during the forecast period of 2022 to 2028. Activated clotting time (ACT) is a test used primarily to monitor high-dose, unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given by injection or […]
Tag Archives: Activated Clotting Time Testing Market
The Activated Clotting Time Testing Market is expected to is growing with the CAGR of 4% in the forecast period of 2022 to 2028. Activated clotting time (ACT) is a test used primarily to monitor high-dose, unfractionated (standard) heparin therapy. Heparin is a drug that inhibits blood clotting (anticoagulant) and is usually given by injection […]